Evidence map›Paper›PMID 32621792›Full record

ArticleESC heart failure2020

The impact of a multidisciplinary cardio-oncology programme on cardiovascular outcomes in Taiwan.

Wei-Ting Chang, Yin-Hsun Feng, Yu Hsuan Kuo, Wei-Yu Chen, Hong-Chang Wu, Chien-Tai Huang, Wen-Ching Wang, Chia-Te Liao, Zhih-Cherng Chen

Abstract readEditorial
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Advancing Cardio-Oncology in Asia.Korean circulation journal · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei-Ting ChangDivision of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Tainan, Taiwan.
Yin-Hsun FengDivision of Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Yu Hsuan KuoDivision of Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Wei-Yu ChenDivision of Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Hong-Chang WuDivision of Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Chien-Tai HuangDivision of Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Wen-Ching WangDivision of General Surgery, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan.
Chia-Te LiaoDivision of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Tainan, Taiwan.
Zhih-Cherng ChenDivision of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Tainan, Taiwan.

Funding

Chi-Mei Medical Center
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical OncologyNeoplasmsHumansTaiwan

Identifiers

PMID32621792
PMCPMC7524067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.